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https://doi.org/10.1016/j.stemcr.2019.01.005SUMMARYIn the CNS, perivascular cells (‘‘pericytes’’) associate with endothelial cells to mediate the formation of tight junctions essential to the
function of the blood-brain barrier (BBB). The BBB protects the CNS by regulating the flow of nutrients and toxins into and out of the
brain. BBB dysfunction has been implicated in the progression of Alzheimer’s disease (AD), but the role of pericytes in BBB dysfunction
in AD is not well understood. In the developing embryo, CNS pericytes originate from two sources: mesoderm and neural crest. In this
study, we report two protocols using mesoderm or neural crest intermediates, to generate brain-specific pericyte-like cells from induced
pluripotent stem cell (iPSC) lines created from healthy and AD patients. iPSC-derived pericytes display stable expression of pericyte
surface markers and brain-specific genes and are functionally capable of increasing vascular tube formation and endothelial barrier
properties.INTRODUCTION
Pericytes are a mural cell type defined by their ‘‘perivascu-
lar’’ association with endothelial cells (ECs) (Armulik
et al., 2011). Found in microvessels throughout the body,
pericytes play a vital role in the remodeling and stabiliza-
tion of developing blood vessels during angiogenesis (Strat-
man et al., 2010; Zhao et al., 2015). Pericytes are also an
essential component of the blood-brain barrier (BBB),
which is a selectively permeable collection of blood vessels
that is also comprised primarily of ECs and astrocytes
(Obermeier et al., 2013; Winkler et al., 2011). The BBB
protects theCNS fromcirculating insults such as pathogens
and immune cells, and mediates the transportation of sub-
stances into and out of the brain. A healthy BBB is
comprised of ECs that form continuous tight junctions,
imparting barrier properties to this structure. Pericytes
wrap around the vasculature formed by ECs and secrete
extracellular matrix proteins into the shared basement
membrane, which provides structural stability to the BBB
(Armulik et al., 2010; Daneman et al., 2010). The abun-
dance of pericytes in the BBB at a pericyte-to-endothelial
ratio between 1:1 and 1:3, compared with peripheral blood
vessels, underscores their importance in maintaining the
health of the CNS. Indeed, pericyte dysfunction has been
implicated in a number of neurodegenerative disorders
including Alzheimer’s disease (AD) (Zhao et al., 2015).
Degeneration of pericytes has been observed in human
postmortem tissue as well asmousemodels of AD (Halliday
et al., 2016; Sagare et al., 2013). Specifically, loss of peri-
cyte coverage and resulting BBB breakdown was observedStem Ce
This is an open access article under the Cin the cortex and hippocampus of ADmousemodels (Niko-
lakopoulou et al., 2017; Winkler et al., 2012). Accumula-
tion of perivascular beta-amyloid (Ab), a hallmark of AD,
has been shown to be toxic to pericytes (Winkler et al.,
2014). In addition, the presence of APOE4, the single great-
est genetic risk factor in late-onset AD, plays a role in peri-
cyte degradation, accumulation of Ab in the CNS, and
breakdown of the BBB (Halliday et al., 2016; Tai et al.,
2016).
Since their identification almost 150 years ago, pericytes
have remained an elusive cell type to characterize due to
their heterogeneous ontogeny. Quail-chick chimeras and
lineage-tracing studies revealed a neural crest (NC) origin
of pericytes destined for the forebrain, while mesoderm
hasbeenshowntogive rise topericytesof thebrainstem, spi-
nal cord, and mid-brain (Etchevers et al., 2001; Korn et al.,
2002; Reyahi et al., 2015). While many cell types can be
identified by expression of unique surface molecules (also
known as ‘‘markers’’), pericytes share expression ofmultiple
markers with other closely related mural cell types such
as smooth muscle cells (Obermeier et al., 2013). Despite
this, a combination of PDGFRb, CD13, CD146, and NG2
surface expression is commonly accepted to be suitable for
distinguishing pericytes from other cell types (Armulik
et al., 2011). Recently, markers to distinguish brain-
resident pericytes from those of the periphery have been
identified. These include FOXF2, VTN, and FOXC1,
although none are entirely unique to pericytes (He et al.,
2016; Reyahi et al., 2015; Siegenthaler et al., 2013).
Pluripotent stem cells (PSCs) provide an alternative
approach to both model and treat diseases. AD patientll Reports j Vol. 12 j 451–460 j March 5, 2019 j ª 2019 The Authors. 451
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induced PSCs (iPSCs) allow the development of in vitro
models of the BBB to improve our understanding of AD-
mediated breakdown of the BBB. While protocols exist to
generate the cell types of the BBB (ECs, astrocytes, and peri-
cytes) from iPSC lines, a method to generate brain-specific
pericytes from iPSCs does not currently exist (Green-
wood-Goodwin et al., 2016; Kumar et al., 2017; Orlova
et al., 2014). To address this, we have developed two
methods that rely on either mesoderm or NC induction
to generate pericytes from iPSCs.RESULTS
Differentiation of hPSCs into Mesoderm and NC
We developed two differentiation protocols to generate
mesoderm- and NC-derived pericytes from human PSCs
(hPSCs) including human embryonic stem cells (hESCs;
H9) or human iPSCs (Figure 1A). Our iPSC lines are derived
from adult AD patients bearing APOE4 (‘‘AD6’’) or APOE3
(‘‘AD22’’) alleles and also healthy patients bearing the
APOE3 allele (‘‘AD5’’), collectively referred to as ‘‘AD’’ lines
(Table S1). To generate iPSC-derived pericytes, we first
differentiated these lines into either mesoderm or NC (Fig-
ure 1A). hPSCs were grown in mesodermal induction
medium (MIM) or a previously described NC induction
medium containing the GSK3 inhibitor, CHIR 99021, to
activate WNT signaling (Leung et al., 2016) (Figure 1A).
After 5 days in culture, MIM-treated hPSCs expressed the
mesodermal marker KDR and mesodermal genes MIXL1
and Brachyury (TBXT), but did not express NC marker
HNK-1 or genes PAX3, PAX7, or TFAP2A (Figures 1B and
1D). While MIM-treated H9 cells expressed the NC marker
CD271, this marker is also known to be expressed in meso-
derm-derived mesenchymal progenitors and, alone, is not
sufficient to identify NCpopulations (Figure 1B) (Cattoretti
et al., 1993; Kumar et al., 2017). Conversely, NC-derived
cells expressed NC markers HNK-1 and CD271 with mild
upregulation of KDR (Figure 1C). All NC-treated hPSC lines
expressed NC genes PAX3, PAX7, and TFAP2A, and did not
express mesodermal genes MIXL1 and TBXT (Figure 1D).
While NC-treated H9 hESCs only mildly upregulatedFigure 1. Differentiation and Characterization of hPSCs into Mes
(A) Schematic diagram of mesoderm (MIM) and NC differentiation
passaged and maintained in pericyte medium (PM) to produce mes
(ncPC).
(B and C) Representative flow cytometry analyses for surface expressi
hPSCs after 5 days in MIM (B) or NC media (C) compared with fluores
(D) qRT-PCR analysis of mesodermal genes TBXT and MIXL1 (left panel
hPSCs after 5 days in MIM (red) or NC media (blue). Gene expression wa
AD5 iPSCs showed similar expression as H9 hPSCs (data not shown).
Mean ± SD was calculated from triplicate reactions of three to six biolo
Student’s unpaired t test (**p < 0.05, ***p < 0.01, ****p < 0.001).PAX7, they expressed high levels of PAX3 and TFAP2A (Fig-
ure 1D). These data indicate that mesoderm and NC cells
can be generated using MIM and NC media, respectively.Pericyte Induction of hPSC-DerivedMesodermandNC
Cells
Following mesoderm and NC induction, cells were
passaged and maintained in pericyte medium, which is a
proprietary medium that supports pericyte growth, to
initiate pericyte differentiation. After 5 days in pericyteme-
dium,mesoderm-derived pericytes (mPCs) andNC-derived
PCs (ncPCs) exhibited high expression of pericyte cell-sur-
face markers PDGFRb, NG2, CD13, and CD146 at levels
comparable with primary human brain vascular pericytes
(HBVPs) (Figure 2A). All three pericyte populations were
negative for expression of the hemato-endothelial marker
CD34 (Figure 2A), and expressed only low levels of the
smooth muscle marker, a-smooth muscle actin (Fig-
ure S1A), further confirming the pericyte-like identity of
the iPSC-PCs. Both mPCs and ncPCs maintained consis-
tent growth rates (Figure S1B) and stable expression of
pericyte markers throughout early to late passages (Figures
S1C and S1D).
To determine the brain specificity ofmPCs andncPCs, we
examined the expression of three recently identified brain
pericyte genes: vitronectin (VTN), and forkhead transcrip-
tion factors FOXF2 and FOXC1. Pericytes secrete VTN,
which upregulates vascular endothelial growth factor A
signaling in ECs, and both FOXC1 and FOXF2 are required
for proper brain pericyte differentiation and angiogenesis
during embryonic development (Reyahi et al., 2015; Sie-
genthaler et al., 2013; Sweeney et al., 2016). qRT-PCR anal-
ysis of these candidate brain-specific pericyte genes
revealed that all three pericyte populations expressed
VTN and FOXC1, although only ncPCs weakly expressed
FOXF2 (Figure 2B). By western blot, VTN and FOXF2 pro-
tein were both expressed across all mPC and ncPC lines
(Figure 2C). Together this indicates that cells bearing
expression of pericyte and brain-specific pericyte genes
can be generated from iPSCs through both mesodermal
and NC routes.oderm and NC-Derived Pericytes
protocols. Five days following MIM and NC induction, cells were
oderm-derived pericytes (mPC) and neural crest-derived pericytes
on of mesodermal marker KDR, and NC markers HNK-1 and CD271 in
cence minus one (FMO) control stain.
) and NC genes PAX3, PAX7, and TFAP2A expression (right panel) in
s calculated relative to undifferentiated H9 hPSCs. Undifferentiated
gical replicates. Statistical significance in was determined using the
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Functional Validation of Pericyte Interactionwith ECs
During embryonic development, brain ECs recruit peri-
cytes to the developing BBB, resulting in their tight associ-
ation which drives maturation of the developing vessel
(Obermeier et al., 2013). Thus, a key functional property
of pericytes is their ability to physically associate with
ECs to support formation of lumenized vascular structures
(Sweeney et al., 2016). To test this capability in hPSC-
derived PCs, we cultured HBVPs, ncPCs, or mPCs in a
semi-solid fibrin gel matrix in a 3D culturing system with
human endothelial colony-forming cell-ECs (ECFC-ECs)
(Figure 3A). ECFC-ECs were chosen as the source of ECs
because these cells are plastic and robust in adapting to a
tissue-specific EC phenotype in the proper native environ-
ment (Sobrino et al., 2016; Wang et al., 2016). ECFC-ECs
cultured alone were unable to form extensive, lumenized
vascular structures. However, when co-cultured with
HBVPs, mPCs, or ncPCs, ECs formed elongated tube-like
structures in close association with the PCs (Figure 3A).
Quantification of EC tube length confirmed observations
that mPCs and ncPCs contribute to vasculogenic tube as-
sembly over ECFC-ECs alone (Figure 3B). These data
demonstrate that both mesoderm- and NC-derived PCs
support vessel growth and maturation.
Effects of Pericytes on Barrier Properties of ECs
Electrical resistance across an endothelial layer is a crucial
physiological property that can be used to examine the
strength of various barrier systems (Srinivasan et al.,
2015). Specifically, the blood-brain barrier exhibits
elevated transendothelial electrical resistance (TEER)
values due to the tight junctions that form between ECs
in the BBB. Multiple groups have shown that TEER values
are significantly elevated in brain ECs cultured with
HBVPs, suggesting that pericytes are essential to the
integrity of an in vitro BBB system (Lippmann et al.,
2014). To test whether ncPCs and mPCs improve TEER
values in a brain vascular context, brain microvessel
endothelial cells (BMECs) were differentiated from AD5
iPSCs according to a previously described protocol (Lipp-
mann et al., 2014). We focused on the healthy patientFigure 2. Gene Expression Analysis of Pericyte Genes in ncPCs an
(A) Representative flow cytometry analysis of pericyte (PDGFRb, NG2, C
brain vascular pericytes (HBVPs) (green, top row), mPC (red, middle r
cells positive for each marker is shown for the stained cell (colored hi
and ncPCs shown were derived from AD5 iPSCs and are representative
(B) qRT-PCR of pericyte genes PDGFRB, ANGPT1, VTN, FOXC1, and FOXF2
ncPCs (blue). Gene expression was normalized to RPLP0 and calculat
actions of three to six biological replicates.
(C) Western blot of FOXF2 (top row) and VTN (middle row) protein i
(bottom row) was used as a loading control.
See also Figure S1.AD5 iPSC line to have a consistent and healthy source
of BMECs across all PC lines. AD5 BMECs, which express
endothelial markers CD144 and GLUT1 (Figure 3C), were
then monocultured or co-cultured with mPCs, ncPCs, or
HBVPs in a transwell system and TEER was measured over
the course of several days (Figure 3D). All PC lines ap-
peared healthy and morphologically normal during the
co-culture in EC medium (EGM2, data not shown).
BMECs cultured alone displayed lower TEER values and,
therefore, weaker barrier properties compared with
BMECs co-cultured with mPCs or ncPCs (Figure 3E).
Peak TEER values were observed 2 days following initia-
tion of co-culture (Figure 3F). These observations were
consistent across BMECs derived from different hPSC
lines including AD22 iPSCs and H9 hESCs (Figure S2).
While BMEC quality, as measured by BMEC-only TEER
values, varied across different experiments, the trends re-
mained the same; maximal TEER is achieved when co-
cultured with pericytes. Furthermore, maximal BMEC
TEER was observed at day 2 of co-culture with pericytes,
which supports the findings of previous studies (Appelt-
Menzel et al., 2017; Lippmann et al., 2014).
Effect of WNT Inhibition on NC-Derived Pericytes
Our results suggest that brain pericytes can be generated
through two distinct pathways. To further investigate the
differences in these two routes, we focused on WNT
signaling, which is required for NC induction but not
mesoderm. Given the important role of WNTs in both
NC induction, brain-specification of ECs, and BBB develop-
ment, we reasoned that inhibition ofWNTsignaling would
also have an impact onNC-derived pericyte induction. The
WNT inhibitor DKK1 was added during mesoderm (Fig-
ure S3) and NC induction of hPSCs (Figure 4). We found
that while WNT inhibition had no effect on mesoderm
induction (Figure S2B), expression of PAX7 appeared
dramatically reduced in NC differentiation when WNT
was inhibited (Figure 4B). However, after 5 days in pericyte
medium, pericyte-like cells with expression of the pericyte
markers PDGFRb and CD146 were observed regardless of
whether WNT was inhibited (DKK1) or activated (CHIR)d mPCs
D13, and CD146) and hemato-endothelial (CD34) markers in human
ow), and ncPC (blue, bottom row). The percentage of differentiated
stograms) compared with the FMO controls (gray histograms). mPCs
of all hPSC lines.
in undifferentiated hPSCs (white), HBVPs (green), mPCs (red), and
ed relative to HBVPs. Mean ± SD was calculated from triplicate re-
n undifferentiated iPSCs, HBVPs, mPCs, and ncPCs. GAPDH protein
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Figure 3. iPSC-Derived Pericytes Promote EC Function
(A) ECFCs (EC, red) and pericytes (PC, green) co-cultured in 3D tube formation assay. ECFCs were cultured alone or co-cultured with HBVPs,
mPCs, and ncPCs and imaged after 1 day (top row) or 4 days (bottom row) in culture. Scale bars, 100 mm.
(B) Percent (%) relative tube length of ECs cultured alone (gray) or with HBVPs (green), mPCs (red), or ncPCs (blue) was calculated relative
to the tube length at day 1 of ECs cultured alone. Mean ± SD was calculated from three to five biological replicates. mPCs and ncPCs were
derived from AD5 iPSCs and are representative of all hPSC-PCs.
(C) Representative flow cytometry analysis of endothelial markers CD144 and GLUT1 in iPSC-derived brain microvessel endothelial cells
(BMECs).
(legend continued on next page)
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Figure 4. Effect of WNT Inhibition on NC-Derived Pericyte Induction
(A) Schematic diagram of NC differentiation protocol supplemented with the WNT activator CHIR99021 (top row) or with the WNT inhibitor
DKK1 (bottom row) for 5 days, then passaged and maintained in pericyte medium (PM).
(B) qRT-PCR analysis of NC gene PAX7 expression in undifferentiated hPSCs (gray) or hPSCs after 5 days in NC supplemented with
CHIR99021 or DKK1. Mean ± SD was calculated from triplicate reactions of two biological replicates.
(C) Representative flow cytometry analysis of pericyte marker expression in pericytes derived from NC supplemented with CHIR99021
(blue) or DKK1 (orange) after passage into PM for 3–7 days. The FMO control (gray histogram) was used to define the gate (dashed line)
used to calculate the percentage of cells positive for each marker, which is shown.
(D) qRT-PCR of pericyte genes VTN, FOXC1, and FOXF2 in cells derived from NC supplemented with CHIR99021 (blue) or DKK1 (orange) after
passage into PM. Gene expression was normalized to RPLP0 and calculated relative to undifferentiated hPSCs (gray). Mean ± SD was
calculated from triplicate reactions of two biological replicates.
See also Figure S3.during NC induction, although other pericyte markers
CD13 and NG2 were downregulated after WNT inhibition
(Figure 4C). DKK1-treated cells also appeared to exhibit(D) Schematic diagram of transwell system used to co-culture BMECs
(TEER).
(E) Representative TEER values of BMECs that were cultured alone (gray
graph). Mean ± SD was calculated from triplicate transwell reactions.
(F) Quantification of peak TEER values at 48 h post co-culture of BMEC
from multiple iPSC lines (H9, AD5, and AD22) and averaged across m
Mean ± SD was calculated from three to six biological replicates in trip
determined using the Student’s unpaired t test (**p < 0.05, ***p < 0lower expression of the brain-specific pericyte genes VTN
and FOXF2, but higher expression of FOXC1 compared
with CHIR-treated cells (Figure 4D). This suggests thatwith pericytes to determine transendothelial electrical resistance
) or with HBVPs (green), mPC (red, left graph), or ncPCs (blue, right
mPCs and ncPCs were derived from AD5 iPSCs.
monocultures compared with co-culture with pericyte lines derived
ultiple experiments.
licate transwell reactions. Statistical significance in (B) and (F) was
.01, ****p < 0.001). See also Figure S2.
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WNT signaling is not necessary for pericyte specification,
although WNT signaling appears to play a role in com-
pleting pericyte development through the NC pathway.DISCUSSION
In this study, we developed two methods to generate brain
pericyte-like cells from hPSCs through mesodermal (mPC)
or neural crest (ncPC) routes. While both mPCs and ncPCs
exhibited similar pericyte gene expression and functional
properties, subtle differences between themwere observed.
Both populations displayed robust marker expression of
PDGFRb, NG2, CD13, and CD146, but FOXF2 gene expres-
sion was higher in ncPCs. During development, FOXF2 is
expressed in the NC, which might explain its higher
expression in ncPCs as opposed to mPCs (Ormestad et al.,
2004). We find that, while mPCs and ncPCs display slight
differences in the expression of certain genes, they are
functionally similar. Surprisingly, despite the requirement
for WNT signaling in NC induction, pericytes could still
be generated via this route when WNT was inhibited.
This raised the possibility that the ncPCs may derive from
a rare population during NC differentiation that is inde-
pendent of WNT. We hypothesized this might be meso-
derm, but there was no TBXT expression in DKK1-treated
NC cells (data not shown). Future RNA sequencing studies
are necessary to determine precisely how similar these two
PC cell types are.
In summary, our study shows that human pericyte-like
cells can be generated from hESCs and iPSCs using two
distinct protocols. Both mesoderm and NC induction
routes are easy to perform, use fully defined serum-free
components, and produce pericytes with consistent
marker expression and functional properties through mul-
tiple passages and freeze-thaw cycles. Both PC types are
easy to transfect, and can be sorted by fluorescence-acti-
vated cell sorting (FACS) if necessary. We have multiple,
independently generated mPC and ncPC lines from a
variety of healthy and AD patient iPSC lines representing
APOE3/3 and APOE4/4 genotypes (Table S1). These peri-
cyte-like cells can be used as a tool to investigate the role
of pericytes in healthy and diseased BBB contexts. Future
studies will compare the impact of APOE polymorphism
on BBB function, which could identify new therapeutic tar-
gets to restore BBB function and mitigate AD pathology.EXPERIMENTAL PROCEDURES
PSC Culture
hPSC lines were cultured in TeSR-E8medium (STEMCELLTechnol-
ogies) onMatrigel-coated plates (Corning). Human iPSC lines were
provided by the University of California Irvine Alzheimer’s Disease458 Stem Cell Reports j Vol. 12 j 451–460 j March 5, 2019Research Center (UCI-ADRC). All procedures using pluripotent
stem cell lines were approved by UCI’s human stem cell research
oversight committee. See Supplemental Experimental Procedures
for more details.Primary Cell Culture
Primary HBVPs (ScienCell) were grown in pericyte medium (1201,
ScienCell) according to themanufacturer’s instructions. ECFC-ECs
were a gift from Dr. Christopher Hughes’ laboratory, and are
cultured in EGM-2 medium (Lonza). See Supplemental Experi-
mental Procedures for more details.Differentiation of hPSCs into Mesoderm and
NC-Derived Pericyte-like Cells
hPSCs were passaged as single cells onto Matrigel-coated plates in
either MIM (STEMCELL Technologies) or a previously described
NC induction medium (Leung et al., 2016) for 5 days to initiate
mesoderm and NC, respectively. Resulting cells were passaged
into pericyte medium (1201, ScienCell) for pericyte specification.
See Supplemental Experimental Procedures for more details.Differentiation of hPSCs into BMECs
BMEC differentiation was performed according to a previously
established protocol (Lippmann et al., 2014). See Supplemental
Experimental Procedures for more details.3D Tube Formation Assay
ECFC-ECs were combinedwith or without HBVPs,mPCs, or ncPCs
in a semi-solid fibrinmatrix at a cell ratio of 50:1. Cells were imaged
everyday using an Olympus FV3000 Laser-Scanning Confocal and
tube length was quantified using Angiotool software. See Supple-
mental Experimental Procedures for more details.Transwell TEER Assay
iPSC-derived BMECs were seeded onto transwell filters (Corning)
that were placed into 12-well plates containing HBVPs, ncPCs, or
mPCs. TEER measurements were made every 24 h. See Supple-
mental Experimental Procedures for more details.SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental
Procedures, three figures, and three tables and can be found
with this article online at https://doi.org/10.1016/j.stemcr.2019.
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